E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries

0:53 Jason intros Sajith Wickramasekara

1:40 What does Benchling do?

2:24 How did Sajith get into life science?

6:55 Benchling's value proposition for scientists

9:04 How do they charge?

10:43 Is Chamath Palihapitiya the most famous Sri Lankan in the US?

13:25 Why immunotherapy is the most exciting development in life science

19:00 3D Printing & harvesting organs in other species

20:50 Ethics of editing a human embryo

28:19 How did the scientific community respond to the embryo controversy

29:52 Breakthroughs in gene therapy

34:09 Defining the line between quackery & brilliance

42:37 Upside & downside of genetically modified crops

47:54 What is the best approach for breakthroughs in life science?

Release date

Lydbog: 6. november 2019